Economic impact based on a scenario analysis to estimate the cost of cardiovascular, renal, bone and neuropsychiatric comorbidities in people living with human immunodeficiency virus in a current scenario versus alternative scenarios that simulate an increase in comorbidities due to toxicity that could be associated with certain treatments, over a 10-year time horizon and from the perspective of the Spanish National Health System.
